The role of NIV in chronic hypercapnic COPD following an acute exacerbation: the importance of patient selection?

Marieke L Duiverman, Wolfram Windisch, Jan H Storre, Peter J Wijkstra, Marieke L Duiverman, Wolfram Windisch, Jan H Storre, Peter J Wijkstra

Abstract

Recently, clear benefits have been shown from long-term noninvasive ventilation (NIV) in stable chronic obstructive pulmonary disease (COPD) patients with chronic hypercapnic respiratory failure. In our opinion, these benefits are confirmed and nocturnal NIV using sufficiently high inspiratory pressures should be considered in COPD patients with chronic hypercapnic respiratory failure in stable disease, preferably combined with pulmonary rehabilitation. In contrast, clear benefits from (continuing) NIV at home after an exacerbation in patients who remain hypercapnic have not been shown. In this review we will discuss the results of five trials investigating the use of home nocturnal NIV in patients with prolonged hypercapnia after a COPD exacerbation with acute hypercapnic respiratory failure. Although some uncontrolled trials might have shown some benefits of this therapy, the largest randomized controlled trial did not show benefits in terms of hospital readmission or death. However, further studies are necessary to select the patients that optimally benefit, select the right moment to initiate home NIV, select the optimal ventilatory settings, and to choose optimal follow up programmes. Furthermore, there is insufficient knowledge about the optimal ventilatory settings in the post-exacerbation period. Finally, we are not well informed about exact reasons for readmission in patients on NIV, the course of the exacerbation and the treatment instituted. A careful follow up might probably be necessary to prevent deterioration on NIV early.

Keywords: chronic obstructive; exacerbation; noninvasive ventilation; pulmonary disease.

Conflict of interest statement

Conflict of interest statement: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

© The Author(s), 2016.

References

    1. Casanova C., Celli B., Tost L., Soriano E., Abreu J., Velasco V., et al. (2000) Long-term controlled trial of nocturnal nasal positive pressure ventilation in patients with severe COPD. Chest 118: 1582–1590.
    1. Cheung A., Chan V., Liong J., Lam J., Leung W., Lin A., et al. (2010) A pilot trial of non-invasive home ventilation after acidotic respiratory failure in chronic obstructive pulmonary disease. Int J Tuberc Lung Dis 14: 642–649.
    1. Chu C., Chan V., Lin A., Wong I., Leung W., Lai C. (2004) Readmission rates and life threatening events in COPD survivors treated with non-invasive ventilation for acute hypercapnic respiratory failure. Thorax 59: 1020–1025.
    1. Clini E., Sturani C., Rossi A., Viaggi S., Corrado A., Donner C. F., et al. (2002) The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients. Eur Respir J 20: 529–538.
    1. Costello R., Deegan P., Fitzpatrick M., McNicholas W. (1997) Reversible hypercapnia in chronic obstructive pulmonary disease: A distinct pattern of respiratory failure with a favorable prognosis. Am J Med 102: 239–244.
    1. Donaldson G., Seemungal T., Bhowmik A., Wedzicha J. (2002) Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 57: 847–852.
    1. Donaldson G., Wilkinson T., Hurst J., Perera W., Wedzicha J. (2005) Exacerbations and time spent outdoors in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 171: 446–452.
    1. Dreher M., Ekkernkamp E., Walterspacher S., Walker D., Schmoor C., Storre J., et al. (2011) Non-invasive ventilation in COPD: Impact of inspiratory pressure levels on sleep quality. Chest 140: 939–945.
    1. Dreher M., Storre H., Schmoor C., Windisch W. (2010) High-intensity versus low-intensity noninvasive ventilation in stable hypercapnic COPD patients: A randomized cross-over trial. Thorax 65: 303–308.
    1. Duiverman M., Wempe J., Bladder G., Jansen D., Kerstjens H., Zijlstra J., et al. (2008) Nocturnal non-invasive ventilation in addition to rehabilitation in hypercapnic patients with COPD. Thorax 63: 1052–1057.
    1. Duiverman M., Wempe J., Bladder G., Vonk J., Zijlstra J., Kerstjens H., et al. (2011) Two-year home-based nocturnal noninvasive ventilation added to rehabilitation in chronic obstructive pulmonary disease patients: a randomized controlled trial. Respir Res 12: 112.
    1. Echave-Sustaeta J., Comeche Casanova L., García Luján R., Sayas Catalan J., Gómez de la Cámara A., López Encuentra A. (2010) Prognosis following acute exacerbation of COPD treated with non-invasive mechanical ventilation. Arch Bronconeumol 46: 405–410.
    1. Funk G., Breyer M., Burghuber O., Kink E., Kirchheiner K., Kohansal R., et al. Long-term non-invasive ventilation in COPD after acute-on-chronic respiratory failure. Respir Med 105: 427–434.
    1. Galli J., Krahnke J., James Mamary A., Shenoy K., Zhao H., Criner G. (2014) Home non-invasive ventilation use following acute hypercapnic respiratory failure in COPD. Respir Med 108: 722–728.
    1. Gay P., Hubmayr R., Stroetz R. (1996) Effectiveness of nocturnal nasal ventilation in stable, severe chronic obstructive pulmonary disease during a 3-month controlled trial. Mayo Clin Proc 71: 533–542.
    1. Global Initiative for Chronic Obstructive Lung Disease (2015) Global Strategy for the Diagnosis, Management and Prevention of COPD. Available from: .
    1. Hurst J., Vestbo J., Anzueto A., Locantore N., Müllerova H., Tal-Singer R., et al. for the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators (2010) Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 363: 1128–1138.
    1. Köhnlein T., Windisch W., Köhler D., Drabik A., Geiseler J., Hartl S., et al. for the COPD study group (2014) Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease. A prospective, multicentre, randomised, controlled clinical trial. Lancet Respir Med 2: 698–705.
    1. Leger P., Bedicam J., Cornette A., Reybet-Degat O., Langevin B., Polu J., et al. (1994) Nasal intermittent positive pressure ventilation. Long-term follow-up in patients with severe chronic respiratory insufficiency. Chest 100: 100–105.
    1. Lin C. (1996) Comparison between nocturnal nasal positive pressure ventilation combined with oxygen therapy and oxygen monotherapy in patients with severe COPD. Am J Respir Crit Care Med 154: 353–358.
    1. Lloyd-Owen S., Donaldson G., Ambrosino N., Escarabill J., Farre R., Fauroux B., et al. (2005) Patterns of home mechanical ventilation use in Europe: results from the Eurovent survey. Eur Respir J 25: 1025–1031.
    1. Lukácsovits J., Carlucci A., Hill N., Ceriana P., Pisani L., Schreiber A., et al. (2012) Physiological changes during low- and high-intensity noninvasive ventilation. Eur Respir J 39: 869–875.
    1. McEvoy R., Pierce R., Hillman D., Esterman A., Ellis E., Catcheside P., et al. (2009) Nocturnal non-invasive nasal ventilation in stable hypercapnic COPD: a randomised controlled trial. Thorax 64: 561–566.
    1. Meecham Jones D., Paul E., Jones P., Wedzicha J. (1995) Nasal pressure support ventilation plus oxygen compared with oxygen therapy alone in hypercapnic COPD. Am J Respir Crit Care Med 152: 538–544.
    1. Nocturnal Oxygen Therapy Trial Group (1980) Continuous or nocturnal oxygen therapy in hypoxaemic chronic obstructive lung disease. Ann Intern Med 93: 39–48.
    1. Ram F., Picot J., Lightowler J., Wedzicha J. (2004) Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 3: CD004104.
    1. Seemungal T., Donaldson G., Paul E., Bestall J., Jeffries D., Wedzicha J. (1998) Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157: 1418–1422.
    1. Simonds A., Elliott M. (1995) Outcome of domiciliary nasal intermittent positive pressure ventilation in restrictive and obstructive disorders. Thorax 50: 604–609.
    1. Soler-Catalu J., Martez-Garc M., Rom Schez P., Salcedo E., Navarro M., Ochando R. (2005) Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 60: 925–931.
    1. Stefan M., Nathanson B., Higgins T., Steingrub J., Lagu T., Rothberg M., et al. (2015) Comparative effectiveness of noninvasive and invasive ventilation in critically ill patients with acute exacerbation of chronic obstructive pulmonary disease. Crit Care Med. [Epub ahead of print]
    1. Struik F., Lacasse Y., Goldstein R., Kerstjens H., Wijkstra P., et al. (2014a) Nocturnal noninvasive positive pressure ventilation in stable COPD. A systematic review and individual patient data meta-analysis. Respir Med 108: 329–337.
    1. Struik F., Sprooten R., Kerstjens H., Bladder G., Zijnen M., Asin J., et al. (2014b) Nocturnal non-invasive ventilation in COPD patients with prolonged hypercapnia after ventilatory support for acute respiratory failure: a randomised, controlled, parallel-group study. Thorax 69: 826–834.
    1. Strumpf D., Millman R., Carlisle C., Grattan L., Ryan S., Erickson A., et al. (1991) Nocturnal positive-pressure ventilation via nasal mask in patients with severe chronic obstructive pulmonary disease. Am Rev Respir Dis 144: 1234–1239.
    1. Tuggey J., Plant P., Elliott M. (2003) Domiciliary non-invasive ventilation for recurrent acidotic exacerbations of COPD: an economic analysis. Thorax 58: 867–871.
    1. Vestbo J. (2004) What is an exacerbation of COPD? Eur Respir Rev 13: 6–13.
    1. Windisch W., Kostic S., Dreher M., Virchow J., Sorichter S., et al. (2005) Outcome of patients with stable COPD receiving controlled noninvasive positive pressure ventilation aimed at a maximal reduction of PaCO2. Chest 128: 657–662.
    1. Windisch W., Vogel M., Sorichter S., Hennings E., Bremer H., Hamm H., et al. (2002) Normocapnia during nIPPV in chronic hypercapnic COPD reduces subsequent spontaneous PaCO2. Respir Med 96: 572–579.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅